GDTC
CytoMed Therapeutics·NASDAQ
--
--(--)
--
--(--)
GDTC Filings
Filing Date
Form Description
Form Type
2026-03-31
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2026-03-31 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-31
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Financials
2026-03-31 · Financials
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026-02-12
Form 144 - Report of proposed sale of securities
Ownership
2026-02-12 · Ownership
Form 144 - Report of proposed sale of securities
2026-01-28
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-28 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-13
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-13 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-08
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-08 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-18
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-18 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-06
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-06 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-29
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-10-29 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-10-22
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-22 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
